Please login to the form below

Not currently logged in
Email:
Password:

Three directors join UK’s MHRA

Valerie Beral, Alexander Markham and David Webb join UK regulatory body

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has named three new non-executive directors.

Valerie Beral, MHRA

Dame Valerie Beral, Prof Sir Alexander Markham and Prof David Webb will all join the board of the MHRA, which regulates the safety of medicines and medical devices in the UK.

Dame Valerie (pictured right) is director of the cancer epidemiology unit at the University of Oxford, where her research has included reproductive, hormonal and infectious agents in cancer.

She also helped lead the Million Women Study, which helped demonstrate that hormone replacement therapy increases a woman's risk of developing breast cancer.

Prof Markham is professor of medicine at the University of Leeds and a former CEO of the charity Cancer Research UK.

He is also director of the molecular medicine unit at St James's University Hospital and chairman of the NHS Connecting for Health Research Capability Programme, in addition to serving on a number of panels of the Medical Research Council.

David Webb, MHRA

Prof Webb (pictured left) is Christison professor of therapeutics and clinical pharmacology at the University of Edinburgh.

His research has focused on internal medicine, hypertension and cardiovascular risk management, and he established Edinburgh University's Wellcome Trust cardiovascular research initiative and centre for cardiovascular science.

In addition to his academic role, he is the current leader of the Scottish Translational Medicine and Therapeutics Initiative (STMTI), established by the Wellcome Trust.

“I'm delighted that Dame Valerie, Sir Alex and Professor Webb have accepted appointments as non-executive directors of the MHRA,” said Sir Gordon Duff, chair of the MHRA.

“They will bring highly relevant experience and expertise to our board at a time of significant development of the Agency, and will contribute importantly to our strategic leadership.

30th July 2013

From: Regulatory

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...

Infographics